Transcutaneous carbon dioxide monitoring as a valid complementary method in acute respiratory failure
Eur Respir J
.
2020 Dec 10;56(6):2002137.
doi: 10.1183/13993003.02137-2020.
Print 2020 Dec.
Authors
Lukas Perkhofer
1
,
Anika Strobel
1
,
Daniel Gagiannis
2
,
Thomas Seufferlein
1
,
Katarina Schmidt
1
,
Benjamin Mayer
3
,
Alexander Kleger
1
4
,
Martin Müller
5
4
Affiliations
1
Dept of Internal Medicine 1, Ulm University, Ulm, Germany.
2
Dept of Pulmonology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.
3
Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
4
A. Kleger and M. Müller contributed equally to this article as lead authors and supervised the work.
5
Dept of Internal Medicine 1, Ulm University, Ulm, Germany martin.mueller@uniklinik-ulm.de.
PMID:
32616592
DOI:
10.1183/13993003.02137-2020
No abstract available
Publication types
Letter
MeSH terms
Blood Gas Monitoring, Transcutaneous
Carbon Dioxide
Humans
Monitoring, Physiologic
Respiratory Distress Syndrome* / diagnosis
Respiratory Distress Syndrome* / therapy
Respiratory Insufficiency* / diagnosis
Substances
Carbon Dioxide